Meeting
2017 ASCO Annual Meeting
Multigene hereditary cancer testing in sarcoma patients.
Authors
Sarah A. Jackson
Genedx, Inc., a Wholly-Owned Subsidiary of Opko Health, Inc., Elmwood Park, NJ
Sarah A. Jackson , Melanie D. Baxter , Jessica Mester , Lisa Susswein , Megan L. Marshall , Kathleen S. Hruska , Rachel T. Klein
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Discussion Session
Session Title
Cancer Prevention, Genetics, and Epidemiology
Track
Prevention, Risk Reduction, and Genetics
Sub Track
Cancer Genetics
Citation
J Clin Oncol 35, 2017 (suppl; abstr 1518)
DOI
10.1200/JCO.2017.35.15_suppl.1518
Abstract #
1518
Poster Bd #
176
Abstract Disclosures
Similar Posters
Poster
2017 ASCO Annual Meeting
Safety of multiplex gene testing for inherited cancer risk in a fully accrued prospective trial.
First Author: Allison W. Kurian
Poster
2023 ASCO Annual Meeting
Spectrum of germline pathogenic variants among patients with cancer in Mexico.
First Author: Jose Luis Rodriguez Olivares
Poster
2019 ASCO Annual Meeting
Tumor sequencing with germline genetic testing: Identification of patients with hereditary cancer and precision treatment eligibility.
First Author: Scott T. Michalski
First Author: Krystal Brown